Matches in Wikidata for { <http://www.wikidata.org/entity/Q67128902> ?p ?o ?g. }
Showing items 1 to 41 of
41
with 100 items per page.
- Q67128902 description "clinical trial" @default.
- Q67128902 description "ensayu clínicu" @default.
- Q67128902 description "klinisch onderzoek" @default.
- Q67128902 description "клінічне випробування" @default.
- Q67128902 name "Phase II Trial for Combination Treatment of PEG-Tα1 and Adefovir for HBeAg Positive Chronic Hepatitis B" @default.
- Q67128902 name "Phase II Trial for Combination Treatment of PEG-Tα1 and Adefovir for HBeAg Positive Chronic Hepatitis B" @default.
- Q67128902 type Item @default.
- Q67128902 label "Phase II Trial for Combination Treatment of PEG-Tα1 and Adefovir for HBeAg Positive Chronic Hepatitis B" @default.
- Q67128902 label "Phase II Trial for Combination Treatment of PEG-Tα1 and Adefovir for HBeAg Positive Chronic Hepatitis B" @default.
- Q67128902 prefLabel "Phase II Trial for Combination Treatment of PEG-Tα1 and Adefovir for HBeAg Positive Chronic Hepatitis B" @default.
- Q67128902 prefLabel "Phase II Trial for Combination Treatment of PEG-Tα1 and Adefovir for HBeAg Positive Chronic Hepatitis B" @default.
- Q67128902 P1050 Q67128902-8AFB4C62-1BBA-49D2-8A24-118EBDA3C5FC @default.
- Q67128902 P1050 Q67128902-D0D9FA39-2E04-4FE2-8266-F9A7129A8802 @default.
- Q67128902 P1050 Q67128902-EE5C1F3E-4BC8-48BD-9948-6FEB6882D401 @default.
- Q67128902 P1132 Q67128902-0B05451F-92F4-4F1E-BE41-EEE5E93E3942 @default.
- Q67128902 P1476 Q67128902-C03A00EE-632F-4EBA-8029-3795EE706E75 @default.
- Q67128902 P1813 Q67128902-E5C75B85-8979-45FC-8590-3787B6369154 @default.
- Q67128902 P2899 Q67128902-EB7519AE-4B74-4E80-BB67-A9263C9B6A6D @default.
- Q67128902 P3098 Q67128902-4CDB8011-08D9-456C-9671-7297692A447E @default.
- Q67128902 P31 Q67128902-59373942-8DAE-4696-9286-A9FE8DE3FD1C @default.
- Q67128902 P4135 Q67128902-48B1DBB3-827C-460A-A3F4-F527E5999CDC @default.
- Q67128902 P4844 Q67128902-E62C098C-4519-460E-9615-CC37ABF70630 @default.
- Q67128902 P580 Q67128902-542F3A76-4F69-44D0-9CD0-89CA3061AD02 @default.
- Q67128902 P582 Q67128902-3420D688-1273-457F-880C-7DF08ED057D5 @default.
- Q67128902 P6099 Q67128902-50317FA3-C9D6-4220-A69E-2191D63CD98F @default.
- Q67128902 P8363 Q67128902-B5E32842-A186-4BB5-A985-33D660D338D9 @default.
- Q67128902 P1050 Q131742 @default.
- Q67128902 P1050 Q157661 @default.
- Q67128902 P1050 Q6853 @default.
- Q67128902 P1132 "+116" @default.
- Q67128902 P1476 "Combination Treatment of Polyethylene Glycol Thymosin alpha1 (PEG-Tα1) and Adefovir for Hepatitis B e Antigen (HBeAg) -Positive Chronic Hepatitis B: A Multi-center Randomized, Double-blind, Parallel-controlled Phase II Trial" @default.
- Q67128902 P1813 "PEG-Tα1" @default.
- Q67128902 P2899 "+18" @default.
- Q67128902 P3098 "NCT02366208" @default.
- Q67128902 P31 Q30612 @default.
- Q67128902 P4135 "+65" @default.
- Q67128902 P4844 Q20817234 @default.
- Q67128902 P580 "2011-05-01T00:00:00Z" @default.
- Q67128902 P582 "2013-06-01T00:00:00Z" @default.
- Q67128902 P6099 Q42824440 @default.
- Q67128902 P8363 Q78089383 @default.